- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00806637
Vessel Sealing System Uvulopalatoplasty Versus Uvulopalatal Flap
December 10, 2008 updated by: Chulalongkorn University
Vessel Sealing System Uvulopalatoplasty vs Uvulopalatal Flap: a Randomized, Control Study of Efficacy and Adverse Effects
The purpose of this study is to compare vessel sealing system uvulopalatoplasty (VSSU) to the traditional uvulopalatal flap (UPF) in the treatment of sleep-disordered breathing with special regard to intraoperative bleeding, operative time, postoperative pain, postoperative hemorrhage and other adverse effects.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Uvulopalatopharyngoplasty is one of the common procedures performed by otolaryngologists to treat sleep-disordered breathing patients who have retropalatal obstruction.
Intraoperative bleeding is a significant problem which requires hemostasis and causes prolonged operative time.
Several different techniques are used to perform this operation, including cold knife, monopolar cautery, coblation, and radiofrequency.
Efficacy in hemostasis and tissue trauma from different operative techniques may result in different operative time and different degrees of morbidity including intraoperative blood loss, postoperative pain, postoperative hemorrhage, and velopharyngeal insufficiency (VPI).
The vessel sealing system has been widely used in head and neck surgery because of its effectiveness and safety.
It was also found quite effective and safe in tonsillectomy procedures, providing excellent hemostasis and minimal tissue trauma.
Study Type
Interventional
Enrollment (Actual)
30
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Bangkok
-
Patumwan, Bangkok, Thailand, 10330
- Department of Otolaryngology, Faculty of Medicine, Chulalongkorn University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient planned for uvulopalatoplasty for indications of snoring or obstructive sleep apnea
- Written informed consent form is given from patient
Exclusion Criteria:
- Pregnancy
- History of bleeding disorders
- Patient unable to understand evaluation method
- Patient unable to be contacted via telephone
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Vessel sealing system uvulopalatoplasty (VSSU) is a new technique for uvulopalatoplasty using a special biclamp forceps for better hemostasis control.
Vessel sealing system (VSS) is a bipolar vascular sealing system, with integrated active feedback control.
The tissue is grasped and compressed by the handpiece.
After the instrument is removed, the seal is visible as a semitransparent window, which can safely be divided.
Uvular tip is grasped with an Allis clamp and retracted back toward the soft palate.
Excision of the uvula and the redundant part of soft palate is performed by the VSS handpiece.
VSS is also used for hemostasis.
|
Vessel sealing system uvulopalatoplasty (VSSU) is a new technique for uvulopalatoplasty using a special biclamp forceps for better hemostasis control.
Vessel sealing system (VSS) is a bipolar vascular sealing system, with integrated active feedback control.
The tissue is grasped and compressed by the handpiece.
After the instrument is removed, the seal is visible as a semitransparent window, which can safely be divided.
Uvular tip is grasped with an Allis clamp and retracted back toward the soft palate.
Excision of the uvula and the redundant part of soft palate is performed by the VSS handpiece.
VSS is also used for hemostasis.
Other Names:
|
|
Active Comparator: 2
Uvulopalatal flap (UPF) is a standard uvulopalatoplasty technique.
Uvulopalatal flap is usually performed as described originally by Powell et al.
The soft palate was injected with 5 to 10 milliliters of 1% lidocaine with epinephrine solution.
The mucosa, submucosa with glands, and fat on the lingual surface of the uvula and soft palate were removed with a scalpel.
Bleeding was controlled with bipolar electrocoagulation.
The uvular tip was amputated, and reflected back toward the soft palate, and fixated into its new position with multiple sutures of 3-0 chromic catgut.
|
Uvulopalatal flap (UPF) is a standard uvulopalatoplasty technique.
Uvulopalatal flap is usually performed as described originally by Powell et al.
The soft palate was injected with 5 to 10 milliliters of 1% lidocaine with epinephrine solution.
The mucosa, submucosa with glands, and fat on the lingual surface of the uvula and soft palate were removed with a scalpel.
Bleeding was controlled with bipolar electrocoagulation.
The uvular tip was amputated, and reflected back toward the soft palate, and fixated into its new position with multiple sutures of 3-0 chromic catgut.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
intraoperative blood loss
Time Frame: within the first 1 hour after surgery starting time
|
within the first 1 hour after surgery starting time
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
operative time
Time Frame: within the first 1 hour after surgery starting time
|
within the first 1 hour after surgery starting time
|
|
postoperative pain
Time Frame: within the first 14 days after surgery
|
within the first 14 days after surgery
|
|
postoperative bleeding
Time Frame: within the first 14 days after surgery
|
within the first 14 days after surgery
|
|
postoperative velopharyngeal insufficiency
Time Frame: within the first 3 months after surgery
|
within the first 3 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Prakobkiat Hirunwiwatkul, M.D., Department of Otolaryngology, Faculty of Medicine, Chulalongkorn University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Lachanas VA, Hajiioannou JK, Karatzias GT, Filios D, Koutsias S, Mourgelas C. Comparison of LigaSure vessel sealing system, harmonic scalpel, and cold knife tonsillectomy. Otolaryngol Head Neck Surg. 2007 Sep;137(3):385-9. doi: 10.1016/j.otohns.2007.05.012.
- Powell N, Riley R, Guilleminault C, Troell R. A reversible uvulopalatal flap for snoring and sleep apnea syndrome. Sleep. 1996 Sep;19(7):593-9. doi: 10.1093/sleep/19.7.593.
- Prokopakis EP, Lachanas VA, Helidonis ES, Velegrakis GA. The use of the Ligasure Vessel Sealing System in parotid gland surgery. Otolaryngol Head Neck Surg. 2005 Nov;133(5):725-8. doi: 10.1016/j.otohns.2005.06.030.
- Bassiouny A, El Salamawy A, Abd El-Tawab M, Atef A. Bipolar radiofrequency treatment for snoring with mild to moderate sleep apnea: a comparative study between the radiofrequency assisted uvulopalatoplasty technique and the channeling technique. Eur Arch Otorhinolaryngol. 2007 Jun;264(6):659-67. doi: 10.1007/s00405-007-0244-x. Epub 2007 Feb 9.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2008
Primary Completion (Anticipated)
May 1, 2009
Study Completion (Anticipated)
September 1, 2009
Study Registration Dates
First Submitted
December 10, 2008
First Submitted That Met QC Criteria
December 10, 2008
First Posted (Estimate)
December 11, 2008
Study Record Updates
Last Update Posted (Estimate)
December 11, 2008
Last Update Submitted That Met QC Criteria
December 10, 2008
Last Verified
October 1, 2008
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ENTCU_pkk2008_02
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.